MedTech POV with Scott Whitaker: Recent Episodes
AdvaMed
Brought to you by the Advanced Medical Technology Association (AdvaMed), MedTech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.
Tune in to each episode for interesting discussions with medtech and health care policy leaders on issues that are driving the day—from business, to policy, and current events, all viewed through the lens of the medtech industry.
Mick Farrell, ResMed CEO and member of the AdvaMed board of directors, joined AdvaMed’s Scott Whitaker on the MedTech POV podcast to discuss how an agile company with skilled staff and a clear mission can pivot sharply as the market demands, from scaling up ventilator production at the outset of the COVID-19 pandemic to informing semiconductor chips manufacturers of their product’s critical importance to the medical technology industry.
Juliana Elstad, President and CEO of Vibrato Medical, recently joined AdvaMed’s Scott Whitaker for a conversation on several policy initiatives that are important for patient care and innovation, including the Transitional Coverage of Emerging Technologies (TCET) proposal before CMS and the Small Business Investment Research (SBIR) program, which is set to expire in September unless Congress acts. They also discussed Elstad’s upbringing in the Soviet Union, her views on the current crisis involving Ukraine and Russia, and her advice for those aspiring to lead a company someday.
Derek Herrera, former Marine and current Board President of MedTechVets, Founder and CEO of Bright Uro, joined AdvaMed’s Scott Whitaker on the MedTech POV podcast to talk about his experiences, from his paralysis by a sniper’s bullet in Afghanistan to his subsequent career as a medtech entrepreneur, and what he sees for the future of the industry.
Watch a heartwarming video of Derek standing up from his wheelchair for the first time in front of his two young sons using exoskeletal medical technology. https://www.youtube.com/watch?v=pCTBn2SSUjg
Mike Mussallem, Chairman and CEO of Edwards Lifesciences joined AdvaMed’s Scott Whitaker on the Medtech POV podcast to talk about changes to federal policy that could speed up the process of getting life-saving medical technology to patients.
Lishan Aklog, MD, Chairman and CEO of PAVmed joined AdvaMed’s Scott Whitaker on the Medtech POV podcast to talk about the way the reimbursement system works for medtech companies and the impact it has on raising capital and getting life-saving medical technology to patients.
Lisa Earnhardt, Executive Vice President, Medical Devices, at Abbott joined AdvaMed’s Scott Whitaker on the Medtech POV podcast to discuss how innovation and technology are helping patients manage diabetes, allowing them to live fuller and better lives.
Nadim Yared, President and CEO of medical technology startup CVRx recently joined AdvaMed’s Scott Whitaker on the Medtech POV Podcast to discuss his expansive career in medtech – from engineer to CEO – and how his work to improve communication between the Food & Drug Administration and the medtech industry has vastly changed over the years.
Nadim Yared, President and CEO of medical technology startup CVRx recently joined AdvaMed’s Scott Whitaker on the Medtech POV Podcast to discuss his expansive career in medtech – from engineer to CEO – and how his work to improve communication between the Food & Drug Administration and the medtech industry has vastly changed over the years.
Justin Klein, cofounder and Managing Partner at Vensana Capital, a top venture capital and growth investment firm focused on funding innovation in the medical technology world, discusses the Medicare Coverage of Innovative Technologies (MCIT) rule and the role venture capital firms like his play overall in the process of bringing promising new medical technologies to market.
Ashley McEvoy, Executive Vice President, Worldwide Chairman, Medical Devices, at Johnson & Johnson recently joined AdvaMed’s Scott Whitaker to discuss her views on leadership, her work with the Trevor Project, and her role as chair of the AdvaMed committee tasked with addressing head-on the issue of racial disparities in health care access and outcomes.
BD Chairman, Chief Executive Officer, and President Tom Polen recently joined AdvaMed’s Scott Whitaker on the Medtech POV podcast to talk about how BD developed and launched COVID-19 diagnostic tests in an unprecedented 90 days. Polen opens up about his role at the leading medical technology company, and how his team of more than 70,000 associates took a three-year development process and condensed it to three months to help people around the globe.
Hologic President and CEO Steve MacMillan leads host Scott Whitaker, president and CEO of AdvaMed, through a retrospective on the company’s more than tripling of total molecular diagnostic manufacturing capacity in order to meet the demands of the COVID-19 pandemic and help save lives.
President and CEO of AdvaMed Scott Whitaker sits down with one of the industry’s top recruiters and head of The Mullings Group, Joe Mullings. Whitaker and Mullings discuss what makes a great leader, how those seeking to work in medtech can navigate the field’s changing dynamics, and how we as an industry and nation can expand access to health care, among other top issues.
Olympus is one of the most important and innovative players in the medical technology industry. At the helm is Nacho Abia, who joins MedTech POV host and AdvaMed CEO Scott Whittaker in this episode to discuss some of the most exciting advances in medtech today. Tune in to hear Abia talk about his role as a leader at Olympus, including a focus on patient-centered care and diversity, equity and inclusion initiatives.
Learn more about Olympus: https://www.olympus-global.com/
A critical department at the FDA, the Center for Devices and Radiological Health (CDRH) is responsible for protecting and promoting the public health through medical device innovation. Dr. Jeffrey Shuren, one of the longest-serving directors of the CDRH, sat down with MedTech POV to share his insight on how medtech and government can work together to solve today’s toughest health challenges.
President and CEO of AdvaMed Scott Whitaker catches up with Dr. Steve Hahn. Before Hahn was the head of FDA, he worked as a medical oncologist, served as a commander in the U.S. Public Health Service Commissioned Corps, managed research for the NIH, and was appointed as the Chief Medical Executive of MD Anderson Cancer Center — all before he was nominated, confirmed, and sworn in as the Commissioner of the Food and Drug Administration in late 2019. Whitaker and Hahn cover many topics, including Dr. Hahn's time as head of FDA during the worst pandemic in a century.
Welcome to the first episode of MedTech POV, a podcast brought to you by AdvaMed, the leading trade organization for medical technology companies, and hosted by CEO, Scott Whitaker. Here at the MedTech POV podast, we’ll give you an up-close look at what’s going on in the medical technology community. Tune in to each episode for conversations with today’s leaders – both inside and outside our industry – about business, policy, and current events.
In this episode, we have with us General James Mattis – a 4-star Marine General who spent more than 40 years commanding forces in the Persian Gulf War, the War in Afghanistan, the Iraq War and, of course, as a former Secretary of Defense. He’s a true leader, he’s one of the best strategic thinkers of our time, and, perhaps above all, he’s a servant of our country in every sense of the word.
General Mattis spoke to our board a few weeks ago, and it was such a great discussion, we decided to share a portion of the discussion and Q&A with you all here.
Listen in a we pick his brain about everything from Covid-19 and international trade relations to how he got his famous call sign, Chaos. And what book does General Mattis think every medtech leader should read? You’ve gotta listen to find out.